SCHEMBL2768063

SCHEMBL2768063

Cc1cc(N2CC(NC(=O)Oc3ccc(Br)s3)CC2=O)ccc1C(=O)N1CCC(O)CC1

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
POLB P06746 3/20 0.42
TP53 P04637 2/20 0.39
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2766681 0.93 LMNA (0.42) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2765445 0.93 LMNA (0.42) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2766124 0.93 LMNA (0.44) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2767202 0.92 LMNA (0.41) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2765569 0.92 LMNA (0.46) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2767137 0.92 LMNA (0.46) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2765646 0.91 LMNA (0.43) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2765785 0.91 LMNA (0.41) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2765159 0.91 POLB (0.41) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2765798 0.91 POLB (0.41) LMNAPOLBTP53KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858890-B1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2010-04-14 EP disclosed
EP-1858890-A1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2007-11-28 EP disclosed
WO-2006089909-A1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-08-31 WO disclosed